The Globe and Mail reports in its Friday, Dec. 19, edition that Desjardins Securities analyst Doug Young continues to rate Manulife Financial "buy," with an unchanged share target of $55. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $55.07. Mr. Young says in a note: "There are four themes we like and, if management delivers, we believe there is room for further valuation multiple expansion. These themes are: (1) core earnings growth across its Asian franchise; (2) momentum in Canada under its new refreshed strategy; (3) reinsuring more lower-ROE legacy businesses, although we do expect less activity on this file vs the past year and a half; and (4) stock buybacks. It s as simple as that!" The Globe reported on Oct. 11, 2024, and April 22, 2025, that Mr. Young had reaffirmed his "buy" recommendation for Manulife Financial when it could be had for $41.82 and $40.39. The Globe reported on Nov. 14, 2025, that Scotia Capital analyst Mike Rizvanovic continued to rate Manulife Financial "sector outperform." The shares could then be had for $48.26.